Mohammed Er-rajy - Concepedia

Author

Mohammed Er-rajy

Sidi Mohamed Ben Abdellah University ORCID

Also Known As

Er-Rajy Mohammed, M. Er-rajy, Mohamed Er-Rajy, Mohammed ER-RAJY, Mohammed Er-Rajy, Mohammed Er-rajy, Mohammed Er-rajy .

Publications

645

Citations

H-Index

Concepts

All Affiliations

Sidi Mohamed Ben Abdellah University King Saud University Princess Nourah bint Abdulrahman University Arab American University Chitkara University

About

Mohammed Er-rajy is an author at Sidi Mohamed Ben Abdellah University specializing in drug discovery, pharmacology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	292
2	Natural Sciences	8	8	304
3	Biochemistry	7	7	279
4	Engineering	2	2	62
5	Biomolecular Engineering	2	2	44

Mohammed Er-rajy

Publications

581

Citations

H-Index

Page 1

	Year	Citations
QSAR, ADMET In Silico Pharmacokinetics, Molecular Docking and Molecular Dynamics Studies of Novel Bicyclo (Aryl Methyl) Benzamides as Potent GlyT1 Inhibitors for the Treatment of Schizophrenia Mohamed El fadili, Mohammed Er-rajy, Mohammed Kara, Pharmaceuticals Medicinal ChemistryAryl MethylDrug TargetBiochemistryFunctional Selectivity	2022	64
Design of novel anti-cancer drugs targeting TRKs inhibitors based 3D QSAR, molecular docking and molecular dynamics simulation Mohammed Er-rajy, Mohamed El fadili, Somdutt Mujwar, Journal of Biomolecular Structure and Dynamics	2023	51
3D-QSAR, ADME-Tox In Silico Prediction and Molecular Docking Studies for Modeling the Analgesic Activity against Neuropathic Pain of Novel NR2B-Selective NMDA Receptor Antagonists Mohamed El fadili, Mohammed Er-rajy, Hamada Imtara, Processes Drug TargetPain MedicineNeuropathic PainMolecular PainPharmacotherapy	2022	49
2D-QSAR modeling, drug-likeness studies, ADMET prediction, and molecular docking for anti-lung cancer activity of 3-substituted-5-(phenylamino) indolone derivatives Mohammed Er-rajy, Mohamed El fadili, Hanine Hadni, Structural Chemistry Medicinal ChemistryBiochemistryMedicineNatural SciencesPharmacology	2022	47
QSAR, ADME-Tox, molecular docking and molecular dynamics simulations of novel selective glycine transporter type 1 inhibitors with memory enhancing properties Mohamed El fadili, Mohammed Er-rajy, Hamada Imtara, Heliyon	2023	42
QSAR, molecular docking, and molecular dynamics simulation–based design of novel anti-cancer drugs targeting thioredoxin reductase enzyme Mohammed Er-rajy, Mohamed El fadili, Somdutt Mujwar, Structural Chemistry Molecular SciencesThioredoxin Reductase EnzymeEngineeringBiochemistryDrug Target	2023	37
Design of novel anti-cancer agents targeting COX-2 inhibitors based on computational studies Mohammed Er-rajy, Mohamed El fadili, Somdutt Mujwar, Arabian Journal of Chemistry PharmacotherapyChemical BiologyTumor BiologyMedicinal ChemistryOncology	2023	37
In-silico screening based on molecular simulations of 3,4-disubstituted pyrrolidine sulfonamides as selective and competitive GlyT1 inhibitors Mohamed El fadili, Mohammed Er-rajy, Wafa Ali Eltayb, Arabian Journal of Chemistry Combinatorial ChemistryDrug TargetBioorganic ChemistryOrganic ChemistryPeptide Science	2023	26
QSAR, molecular docking, ADMET properties in silico studies for a series of 7-propanamide benzoxaboroles as potent anti-cancer agents Mohammed Er-rajy, Mohamed El fadili, Nidal Naceiri Mrabti, Chinese Journal of Analytical Chemistry Medicinal Chemistry7-Propanamide BenzoxaborolesMedicineNatural SciencesPharmacology	2022	25
3D-QSAR Studies, Molecular Docking, Molecular Dynamic Simulation, and ADMET Proprieties of Novel Pteridinone Derivatives as PLK1 Inhibitors for the Treatment of Prostate Cancer Mohammed Er-rajy, Mohamed El fadili, Hamada Imtara, Life EngineeringNovel Pteridinone DerivativesPharmacotherapyMolecular DynamicsPharmaceutical Chemistry	2023	25

Page 1